Bromind-T Eye Drops

Bromind-T Eye Drops – Brimonidine Tartrate & Timolol Maleate

Bromind-T Eye Drops are an ophthalmic combination containing Brimonidine Tartrate and Timolol Maleate. The combination is used to reduce elevated intraocular pressure in patients with glaucoma or ocular hypertension when intraocular pressure is not adequately controlled with existing treatment.

Brimonidine is an alpha-adrenergic receptor agonist, while Timolol is a beta-adrenergic receptor inhibitor. Their complementary mechanisms help lower intraocular pressure through different pathways. 

What Are Bromind-T Eye Drops Used For?

Bromind-T Eye Drops are used for the reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension.

They may be prescribed when additional therapy is required or when existing treatment needs to be replaced because intraocular pressure remains inadequately controlled.

Uses of Bromind-T Eye Drops

Bromind-T may be used for:

• Glaucoma

• Ocular hypertension

• Elevated intraocular pressure

• Reduction of intraocular pressure in patients requiring combination therapy

• Patients whose intraocular pressure is inadequately controlled with existing ophthalmic treatment

Glaucoma

Glaucoma is a group of eye disorders associated with damage to the optic nerve. Elevated intraocular pressure is an important risk factor for progression in many patients with glaucoma.

Lowering intraocular pressure is an important part of glaucoma management. Brimonidine and Timolol work through different pharmacological mechanisms to reduce intraocular pressure. 

Ocular Hypertension

Ocular hypertension refers to higher-than-normal pressure inside the eye without necessarily having established glaucomatous optic nerve damage.

Patients with elevated intraocular pressure may require medical management depending on their individual risk factors and clinical assessment.

Brimonidine/Timolol ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with ocular hypertension when appropriate combination or replacement therapy is required. 

How Does Bromind-T Work?

Bromind-T combines two medicines with complementary mechanisms of action.

Brimonidine Tartrate is an alpha-adrenergic receptor agonist that helps reduce intraocular pressure.

Timolol Maleate is a beta-adrenergic receptor inhibitor that also lowers intraocular pressure.

The combination provides an additional mechanism for reducing intraocular pressure compared with treatment using either mechanism alone. 

Reduction of Intraocular Pressure

The primary therapeutic objective of Bromind-T is to lower elevated intraocular pressure.

Clinical labeling for the Brimonidine/Timolol combination specifically identifies reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension as its indication.

Product Information

Brand Name: Bromind-T

Composition: Brimonidine Tartrate & Timolol Maleate Eye Drops

Active Ingredients: Brimonidine Tartrate and Timolol Maleate

Dosage Form: Ophthalmic Solution / Eye Drops

Route of Administration: Ophthalmic

Packing: 5 ml

Therapeutic Class: Antiglaucoma / Intraocular Pressure-Lowering Ophthalmic Medicine

Primary Applications: Glaucoma and Ocular Hypertension

Key Product Features

• Combination ophthalmic formulation

• Contains Brimonidine Tartrate and Timolol Maleate

• Alpha-adrenergic agonist + beta-blocker combination

• Used for reduction of elevated intraocular pressure

• Used in glaucoma

• Used in ocular hypertension

• 5 ml eye-drop presentation

Important Information

Bromind-T Eye Drops should be used under the supervision of a qualified healthcare professional.

The dosage and treatment duration should be determined according to the patient's condition and the prescribing information.

The currently approved labeling for the standard Brimonidine/Timolol combination recommends ophthalmic administration according to the prescribed regimen. 

Patients should inform their healthcare professional about existing medical conditions and all medicines they are taking before starting treatment.

Because Timolol is a beta-adrenergic receptor inhibitor, ophthalmic administration can produce systemic beta-blocking effects. Appropriate medical evaluation is important, particularly in patients with respiratory or cardiovascular conditions. 

The product is contraindicated in certain patients, including those with bronchial asthma or a history of bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, certain heart conduction disorders, overt cardiac failure, cardiogenic shock or hypersensitivity to the ingredients, according to the applicable prescribing information. 

Patients should follow the approved prescribing information and medical advice for correct administration and treatment.

Storage

Store the product according to the storage conditions specified on the approved product label.

Keep the container properly closed when not in use and keep it out of reach of children.

Product Summary

Bromind-T Eye Drops contain Brimonidine Tartrate and Timolol Maleate, a combination ophthalmic formulation used to reduce elevated intraocular pressure.

It is used in patients with glaucoma or ocular hypertension when additional or replacement therapy is required because intraocular pressure is inadequately controlled.

Brimonidine acts as an alpha-adrenergic receptor agonist and Timolol acts as a beta-adrenergic receptor inhibitor. Together, they provide complementary mechanisms for lowering intraocular pressure.